These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

768 related items for PubMed ID: 21221047

  • 1. Combined intratympanic and systemic use of steroids for idiopathic sudden sensorineural hearing loss.
    Arslan N, Oğuz H, Demirci M, Şafak MA, İslam A, Kaytez SK, Samim E.
    Otol Neurotol; 2011 Apr; 32(3):393-7. PubMed ID: 21221047
    [Abstract] [Full Text] [Related]

  • 2. Intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss: a control study.
    Xenellis J, Papadimitriou N, Nikolopoulos T, Maragoudakis P, Segas J, Tzagaroulakis A, Ferekidis E.
    Otolaryngol Head Neck Surg; 2006 Jun; 134(6):940-5. PubMed ID: 16730534
    [Abstract] [Full Text] [Related]

  • 3. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.
    Haynes DS, O'Malley M, Cohen S, Watford K, Labadie RF.
    Laryngoscope; 2007 Jan; 117(1):3-15. PubMed ID: 17202923
    [Abstract] [Full Text] [Related]

  • 4. Intratympanic and systemic steroids for sudden hearing loss.
    Koltsidopoulos P, Bibas A, Sismanis A, Tzonou A, Seggas I.
    Otol Neurotol; 2013 Jun; 34(4):771-6. PubMed ID: 23652330
    [Abstract] [Full Text] [Related]

  • 5. Intratympanic steroids for treatment of sudden hearing loss after failure of intravenous therapy.
    Plaza G, Herráiz C.
    Otolaryngol Head Neck Surg; 2007 Jul; 137(1):74-8. PubMed ID: 17599569
    [Abstract] [Full Text] [Related]

  • 6. Intratympanic steroid injections as a salvage treatment for sudden sensorineural hearing loss: a randomized, double-blind, placebo-controlled study.
    Wu HP, Chou YF, Yu SH, Wang CP, Hsu CJ, Chen PR.
    Otol Neurotol; 2011 Jul; 32(5):774-9. PubMed ID: 21646929
    [Abstract] [Full Text] [Related]

  • 7. Intratympanic methylprednisolone for sudden sensorineural hearing loss.
    Kiliç R, Safak MA, Oğuz H, Kargin S, Demirci M, Samim E, Ozlüoğlu LN.
    Otol Neurotol; 2007 Apr; 28(3):312-6. PubMed ID: 17414035
    [Abstract] [Full Text] [Related]

  • 8. [The effect of intratympanic dexamethasone or methylprednisolone on treatment of sudden sensorineural hearing loss].
    Yang J, Huang L, Shi J, Li Y, Wu H, Kong W.
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Jul; 24(13):594-7. PubMed ID: 20842947
    [Abstract] [Full Text] [Related]

  • 9. Simultaneous versus subsequent intratympanic dexamethasone for idiopathic sudden sensorineural hearing loss.
    Park MK, Lee CK, Park KH, Lee JD, Lee CG, Lee BD.
    Otolaryngol Head Neck Surg; 2011 Dec; 145(6):1016-21. PubMed ID: 21817157
    [Abstract] [Full Text] [Related]

  • 10. Intratympanic dexamethasone/hyaluronic acid mix as an adjunct to intravenous steroid and vasoactive treatment in patients with severe idiopathic sudden sensorineural hearing loss.
    Gouveris H, Schuler-Schmidt W, Mewes T, Mann W.
    Otol Neurotol; 2011 Jul; 32(5):756-60. PubMed ID: 21646933
    [Abstract] [Full Text] [Related]

  • 11. Therapy of idiopathic sudden sensorineural hearing loss with intratympanic steroid injection.
    Khaimook W, Jantarapattana K.
    J Med Assoc Thai; 2011 Dec; 94(12):1495-9. PubMed ID: 22295738
    [Abstract] [Full Text] [Related]

  • 12. Systemic, intratympanic and combined administration of steroids for sudden hearing loss. A prospective randomized multicenter trial.
    Tsounis M, Psillas G, Tsalighopoulos M, Vital V, Maroudias N, Markou K.
    Eur Arch Otorhinolaryngol; 2018 Jan; 275(1):103-110. PubMed ID: 29168028
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of 3 different steroid treatments for sudden sensorineural hearing loss: a prospective, randomized trial.
    Lim HJ, Kim YT, Choi SJ, Lee JB, Park HY, Park K, Choung YH.
    Otolaryngol Head Neck Surg; 2013 Jan; 148(1):121-7. PubMed ID: 23077155
    [Abstract] [Full Text] [Related]

  • 14. Intratympanic steroid injection for treatment of idiopathic sudden hearing loss.
    Slattery WH, Fisher LM, Iqbal Z, Friedman RA, Liu N.
    Otolaryngol Head Neck Surg; 2005 Aug; 133(2):251-9. PubMed ID: 16087024
    [Abstract] [Full Text] [Related]

  • 15. Hearing evaluation of intratympanic methylprednisolone perfusion for refractory sudden sensorineural hearing loss.
    She W, Dai Y, Du X, Yu C, Chen F, Wang J, Qin X.
    Otolaryngol Head Neck Surg; 2010 Feb; 142(2):266-71. PubMed ID: 20115986
    [Abstract] [Full Text] [Related]

  • 16. Therapeutic efficacy of the combination of intratympanic methylprednisolone and oral steroid for idiopathic sudden deafness.
    Gundogan O, Pinar E, Imre A, Ozturkcan S, Cokmez O, Yigiter AC.
    Otolaryngol Head Neck Surg; 2013 Nov; 149(5):753-8. PubMed ID: 23959817
    [Abstract] [Full Text] [Related]

  • 17. Intratympanic methylprednisolone in refractory sudden hearing loss: a 27-patient case series with univariate and multivariate analysis.
    Dallan I, De Vito A, Fattori B, Casani AP, Panicucci E, Berrettini S, Marchetti M, Nacci A.
    Otol Neurotol; 2010 Jan; 31(1):25-30. PubMed ID: 19940792
    [Abstract] [Full Text] [Related]

  • 18. Systemic steroid versus combined systemic and intratympanic steroid treatment for sudden sensorineural hearing loss.
    Baysal E, Tunç O, Baglam T, Durucu C, Oz A, Karatas ZA, Polat M, Celenk F, Mumbuc S, Kanlikama M.
    J Craniofac Surg; 2013 Mar; 24(2):432-4. PubMed ID: 23524709
    [Abstract] [Full Text] [Related]

  • 19. Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy.
    Plontke SK, Löwenheim H, Mertens J, Engel C, Meisner C, Weidner A, Zimmermann R, Preyer S, Koitschev A, Zenner HP.
    Laryngoscope; 2009 Feb; 119(2):359-69. PubMed ID: 19172627
    [Abstract] [Full Text] [Related]

  • 20. Corticosteroid treatment of idiopathic sudden sensorineural hearing loss: randomized triple-blind placebo-controlled trial.
    Nosrati-Zarenoe R, Hultcrantz E.
    Otol Neurotol; 2012 Jun; 33(4):523-31. PubMed ID: 22429944
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.